Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Hiroya, Takiuchi"'
Autor:
Hisahiro Matsubara, Motoyasu Kusano, Hiroyuki Kato, Yoshio Naomoto, Hiroyuki Kuwano, Yuko Kitagawa, Yasushi Toh, Manabu Muto, Akio Yanagisawa, Yasumasa Nishimura, Tsuneo Oyama, Tatsuya Miyazaki, Hideo Shimada, Yuichiro Doki, Hiroya Takiuchi
Publikováno v:
Esophagus
Purpose These guidelines are intended for doctors who are engaged in the diagnosis and treatment of esophageal carcinoma, for the following purposes: (1) to present the standard practice for the diagnosis and treatment of esophageal carcinoma with a
Autor:
Toru Naito, Hiroya Takiuchi, Shinsuke Mizutani, Tomotaka Kato, Takashi Hanioka, Seiichi Sugiyama
Publikováno v:
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health; Volume 14; Issue 8; Pages: 880
International Journal of Environmental Research and Public Health, Vol 14, Iss 8, p 880 (2017)
International Journal of Environmental Research and Public Health; Volume 14; Issue 8; Pages: 880
International Journal of Environmental Research and Public Health, Vol 14, Iss 8, p 880 (2017)
The presence of any age-related differences in gingival pigmentation associated with smoking, particularly in a young population, remains to be fully investigated. The purpose of this study was to determine the age-related differences in smoking ging
Autor:
Tomoko Katayama-Ono, Takashi Hanioka, Seiichi Sugiyama, Satoshi Noguchi, Hiroya Takiuchi, Tomotaka Kato, Toru Naito, Michiko Makino
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 13; Issue 6; Pages: 598
International Journal of Environmental Research and Public Health, Vol 13, Iss 6, p 598 (2016)
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health, Vol 13, Iss 6, p 598 (2016)
International Journal of Environmental Research and Public Health
Background: Due to moisture and the anatomical complexity of the oral mucosa, it is difficult to measure the extent of gingival melanosis in an optical manner. Therefore, we developed a new quantitative method using clinical oral photographs and comp
Autor:
Y Kinugasa, Naohiro Tomita, H Shinozaki, Yasumasa Takii, Narikazu Boku, Y Matsubara, Hiroya Takiuchi, Keiichi Takahashi, Kenichi Sugihara, Izumi Mochizuki, Mamoru Watanabe, T Endo, Shingo Kameoka, Akinori Takagane, K. Ikejiri, Hidetaka Mochizuki, Y Nakamoto, Toshiaki Watanabe, Yusuke Takahashi, Kenjiro Kotake
Publikováno v:
British Journal of Cancer
Background: The Adjuvant Chemotherapy Trial of TS-1 for Colon Cancer (ACTS-CC) is a phase III trial designed to validate the non-inferiority of S-1 to UFT/leucovorin (LV) as postoperative adjuvant chemotherapy for stage III colon cancer. We report th
Autor:
Yutaka Kimura, Hiroshi Imamura, Toshimasa Tsujinaka, Toshio Shimokawa, A.H. Kwon, Yukinori Kurokawa, H. Furukawa, S. Okano, Kentaro Inoue, Y. Nakane, Kazumasa Fujitani, Shigeyuki Tamura, Hiroya Takiuchi, M. Kogire
Publikováno v:
European Journal of Surgical Oncology (EJSO). 38:143-149
Background The aim of this study was to evaluate the efficacy and feasibility of preoperative chemotherapy with S-1 plus cisplatin in patients with initially unresectable locally advanced gastric cancer. Methods We enrolled patients with initially un
Autor:
Yasuo Hamamoto, Taroh Satoh, Atsushi Ohtsu, Eishi Baba, Kiyohiko Hatake, Kensei Yamaguchi, Tomohiro Nishina, Hiroya Takiuchi, Yasutsuna Sasaki, Takao Tamura, Akira Sawaki, Atsushi Satoh, Yasuo Ohashi, Yasushi Omuro, Yoshinori Miyata, Narikazu Boku, Takashi Abe
Publikováno v:
Gastric Cancer
Background The Trastuzumab for Gastric Cancer (ToGA) study is the first international trial to include Japanese patients with human epidermal growth factor 2 (HER2) positive advanced/metastatic gastric or gastroesophageal junction cancer. ToGA showed
Autor:
Haruhiko Fukuda, Yoshito Komatsu, Kei Muro, Keiko Minashi, Narikazu Boku, Atsushi Ohtsu, Yoshinori Miyata, Hiroya Takiuchi, Satoshi Ishikura, Ken Kato
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 81:684-690
Purpose In this Phase II study, we evaluated the efficacy and toxicity of chemoradiotherapy (CRT) with cisplatin (CDDP) and 5-fluorouracil (5-FU) for Stage II–III esophageal squamous cell carcinoma (ESCC). Patients and Methods Patients with clinica
Autor:
Toshiaki, Watanabe, Michio, Itabashi, Yasuhiro, Shimada, Shinji, Tanaka, Yoshinori, Ito, Yoichi, Ajioka, Tetsuya, Hamaguchi, Ichinosuke, Hyodo, Masahiro, Igarashi, Hideyuki, Ishida, Megumi, Ishiguro, Yukihide, Kanemitsu, Norihiro, Kokudo, Kei, Muro, Atsushi, Ochiai, Masahiko, Oguchi, Yasuo, Ohkura, Yutaka, Saito, Yoshiharu, Sakai, Hideki, Ueno, Takayuki, Yoshino, Takahiro, Fujimori, Nobuo, Koinuma, Takayuki, Morita, Genichi, Nishimura, Yuh, Sakata, Keiichi, Takahashi, Hiroya, Takiuchi, Osamu, Tsuruta, Toshiharu, Yamaguchi, Masahiro, Yoshida, Naohiko, Yamaguchi, Kenjiro, Kotake, Kenichi, Sugihara
Publikováno v:
International Journal of Clinical Oncology. 17:1-29
Colorectal cancer is a major cause of death in Japan, where it accounts for the largest number of deaths from malignant neoplasms in women and the third largest number in men. Many new treatment methods have been developed over the last few decades.
Autor:
Hiroya Takiuchi
Publikováno v:
Gastric Cancer. 14:206-211
Chemotherapy for gastric cancer has been advancing fairly well. It has been indicated that not only advances in first-line chemotherapy but also those in second-line chemotherapy have contributed to the prolongation of overall survival. The Arbeitsge
Autor:
Tetsuya, Hamaguchi, Kuniaki, Shirao, Atsushi, Ohtsu, Ichinosuke, Hyodo, Yasuaki, Arai, Hiroya, Takiuchi, Hirofumi, Fujii, Motoki, Yoshida, Hiroshi, Saito, Tadamichi, Denda, Wasaburo, Koizumi, Hiroaki, Iwase, Narikazu, Boku, M, Yoshida
Publikováno v:
Gastric Cancer. 14:226-233
Preclinical studies have shown that mitomycin C (MMC) acts synergistically with irinotecan (CPT-11). In this phase II study, we evaluated the efficacy and toxicity of MMC/CPT-11 therapy as second-line chemotherapy for patients with fluoropyrimidine-r